Abbott India EV/EBIT
Quel est le EV/EBIT de Abbott India?
Le EV/EBIT de Abbott India Limited est 39.90
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur BSE par rapport à Abbott India
Que fait Abbott India?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolics, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was founded in 1944 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Laboratories
Entreprises avec ev/ebit similaire à Abbott India
- CAST SA a EV/EBIT de 39.82
- Lonza AG a EV/EBIT de 39.83
- Zenith Healthcare a EV/EBIT de 39.87
- CR Constr Grp Hldg Ltd a EV/EBIT de 39.88
- Terreno Realty Corp a EV/EBIT de 39.89
- Tiffany & Co a EV/EBIT de 39.90
- Abbott India a EV/EBIT de 39.90
- Neogen Chemicals a EV/EBIT de 39.92
- The Bombay Dyeing and Manufacturing a EV/EBIT de 39.94
- GHP Noetic Science-Psychedelic Pharma a EV/EBIT de 39.95
- N.B.I. Industrial Finance a EV/EBIT de 39.95
- Texmaco Rail & Engineering a EV/EBIT de 39.96
- Shift4 Payments a EV/EBIT de 39.97